Company Overview and News

 
Vodafone Malta and Melita Ltd to Merge

2017-05-24 londonstockexchange
Apax Partners Midmarket SAS ("Apax"), Fortino Capital ("Fortino") and Vodafone Group Plc ("Vodafone") today announced an agreement to combine Melita Ltd ("Melita") and Vodafone Malta Ltd ("Vodafone Malta") (together, the "Combined Company").
Upvote Downvote

 
BRIEF-Accenture acquires solid servision to significantly expand servicenow capabilities

2017-01-25 reuters
* Accenture acquires solid servision to significantly expand servicenow capabilities Source text for Eikon: Further company coverage:
Upvote Downvote

 
BRIEF-Tata Consultancy Services and Gfi Informatique unveil technology to enhance urban transportation in Belfort, France

2017-01-25 reuters
* Tata Consultancy Services and Gfi Informatique unveil smart city technology to enhance urban transportation in Belfort, France Source text for Eikon: Further company coverage: (Gdynia Newsroom)
Upvote Downvote

 
Tata Consultancy Services and Gfi Informatique Unveil Smart City Technology to Enhance Urban Transportation in Belfort, France

2017-01-25 prnewswire
BELFORT, France, Jan. 25, 2017 /PRNewswire/ -- Tata Consultancy Services (TCS), (BSE: 532540, NSE: TCS) a leading global IT services, consulting and business solutions organization and Gfi Informatique, a major vendor of value-added IT services and software, today announced a Proof of Concept for the City of Belfort, France using big data analytics to optimize urban bus transportation.
Upvote Downvote

 
TCS, Gfi Informatique unveil smart city solution in France

2017-01-25 moneycontrol
Ensure that your correct email id and mobile has been registered with moneycontrol. If not, please update your profile and secure the account now. Updating your email id and mobile number offers following benefits:
Upvote Downvote

 
Agreement reached between Laureate Education, Inc. and Apax Partners for the sale of Laureate's higher education interests in France. Bpifrance will co-invest alongside Apax Partners.

2016-04-19 prnewswire
BALTIMORE, April 19, 2016 /PRNewswire/ -- Laureate Education, Inc., the largest global network of degree-granting higher education institutions, today announced that it has signed an agreement for the transfer of control of Laureate International Universities France SAS ('LIUF'), a French holding entity, to Apax Partners, a leading private equity firm in French-speaking European countries. Bpifrance, the investment vehicle of the French state, will co-invest alongside Apax Partners and hold around 10% of the entity.
Upvote Downvote

 
EU mergers and takeovers (Jan 26)

2016-01-26 reuters
BRUSSELS Jan 26 The following are mergers under review by the European Commission and a brief guide to the EU merger process:
Upvote Downvote

 
EU mergers and takeovers (Jan 22)

2016-01-22 reuters
BRUSSELS Jan 22 The following are mergers under review by the European Commission and a brief guide to the EU merger process:
Upvote Downvote

 
EU mergers and takeovers (Jan 21)

2016-01-21 reuters
BRUSSELS Jan 21 The following are mergers under review by the European Commission and a brief guide to the EU merger process:
Upvote Downvote

 
EU mergers and takeovers (Jan 19)

2016-01-19 reuters
BRUSSELS Jan 19 The following are mergers under review by the European Commission and a brief guide to the EU merger process:
Upvote Downvote

Related Articles

LPCN: Lipocine Inc Analysis and Research Report

2018-04-23 - Asif

Overview Lipocine is a specialty pharmaceutical company focused on applying its oral drug delivery technology for the development of pharmaceutical products in the area of men’s and women’s health. The company's proprietary delivery technologies are designed to improve patient compliance and safety through orally available treatment options. The company's primary development programs are based on oral delivery solutions for poorly bioavailable drugs. Lipocine has a portfolio of proprietary product candidates designed to produce favorable pharmacokinetic (“PK”) characteristics and facilitate lower dosing requirements, bypass first-pass metabolism in certain cases, reduce side effects, and eliminate gastrointestinal interactions that limit bioavailability. The company's lead product candidate, TLANDO™, is an oral testosterone replacement therapy (“TRT”) and is currently under review by the United States Food and Drug Administration (“FDA”) with a Prescription Drug User Fee Act (“...

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...